Hiroshi Wataya

736 total citations
41 papers, 558 citations indexed

About

Hiroshi Wataya is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroshi Wataya has authored 41 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 8 papers in Surgery. Recurrent topics in Hiroshi Wataya's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (9 papers) and Cancer therapeutics and mechanisms (5 papers). Hiroshi Wataya is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (9 papers) and Cancer therapeutics and mechanisms (5 papers). Hiroshi Wataya collaborates with scholars based in Japan, Australia and United States. Hiroshi Wataya's co-authors include Yukito Ichinose, Riichiroh Maruyama, Tatsuro Okamoto, Yoichi Nakanishi, Koichi Takayama, Takashi Seto, Nobuyuki Hara, Fumihiro Shoji, Takahiro Minami and Ryuichi Suemitsu and has published in prestigious journals such as Cancer, Scientific Reports and European Journal of Cancer.

In The Last Decade

Hiroshi Wataya

39 papers receiving 543 citations

Peers

Countries citing papers authored by Hiroshi Wataya

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Wataya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Wataya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Wataya more than expected).

Fields of papers citing papers by Hiroshi Wataya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Wataya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Wataya. The network helps show where Hiroshi Wataya may publish in the future.

Co-authorship network of co-authors of Hiroshi Wataya

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Wataya. A scholar is included among the top collaborators of Hiroshi Wataya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Wataya. Hiroshi Wataya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interpleural distance predicts persistent air leak after initial primary spontaneous pneumothorax 2020 ·Journal of Thoracic Disease ·Takaki Akamine, Takuro Kometani, (unknown), Shinji Akamine, Yasunori Shikada, Hiroshi Wataya	4
2	Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408 2019 ·Journal of Clinical Medicine ·Koichi Takayama, Junji Uchino, Masaki Fujita, Shoji Tokunaga, (unknown), Ryotaro Morinaga, Noriyuki Ebi, Sho Saeki, (unknown), Hiroshi Wataya, Tadaaki Yamada, Yoichi Nakanishi	1
3	Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer 2017 ·OncoTargets and Therapy ·Masao Ichiki, Hiroshi Wataya, Kazuhiko Yamada, Nobuko Tsuruta, Hiroaki Takeoka, (unknown), Junichi Sasaki, Tomoaki Hoshino	20
4	Emphysematous Pyelonephritis and Cystitis: Unusual Adverse Events during Concurrent Chemoradiotherapy for Lung Cancer 2017 ·Case Reports in Oncology ·(unknown), (unknown), (unknown), (unknown), Hiroshi Wataya	4
5	The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study 2016 ·Journal of Infection and Chemotherapy ·Masaki Fujita, Takemasa Matsumoto, (unknown), Hiroshi Wataya, Koichi Takayama, Masayuki Ishida, Noriyuki Ebi, Junji Kishimoto, Yukito Ichinose	3
6	Prognosis and therapeutic response according to the world health organization histological classification in advanced thymoma 2011 ·Surgery Today ·Tetsuzo Tagawa, Takuro Kometani, Koji Yamazaki, Tatsuro Okamoto, Hiroshi Wataya, Takashi Seto, Seiichi Fukuyama, Atsushi Osoegawa, Fumihiko Hirai, Kenji Sugio, Yukito Ichinose	5
7	Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer 2010 ·Journal of Infection and Chemotherapy ·Masaki Fujita, Hiroshi Ouchi, (unknown), Yuichi Inoue, Ichiro Inoshima, Yoichi Nakanishi, Chikara Yoshimura, Hiroshi Wataya, Masayuki Kawasaki, (unknown)	6
8	Non‐small cell lung carcinoma of the superior sulcus: The evolution of treatment outcomes with multimodality treatment at a single institution 2010 ·Journal of Surgical Oncology ·Tetsuzo Tagawa, Atsushi Osoegawa, Koji Yamazaki, Tatsuro Okamoto, Takuro Kometani, Hiroshi Wataya, Takashi Seto, Seiichi Fukuyama, Fumihiko Hirai, Kenji Sugio, Yukito Ichinose	3
9	Tegafur-Uracil Plus Gemcitabine Combination Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Platinum 2008 ·Journal of Thoracic Oncology ·Takashi Seto, Takeharu Yamanaka, Makiko Nakano, (unknown), Riichiroh Maruyama, Tatsuro Okamoto, Hiroshi Wataya, Kazutsugu Uematsu, Nobuhiko Seki, Kenji Eguchi, Hiroshi Semba, Yukito Ichinose	2
10	A Phase II Trial of Gefitinib Monotherapy in Chemotherapy-Naïve Patients of 75 Years or Older with Advanced Non-small Cell Lung Cancer 2008 ·Journal of Thoracic Oncology ·Noriyuki Ebi, Hiroshi Semba, (unknown), Koichi Takayama, Hiroshi Wataya, Takashige Kuraki, Hidehiko Yamamoto, (unknown), Isamu Okamoto, Yoichi Nakanishi	37
11	Prognostic factors in previously treated non-small cell lung cancer patients with and without a positive response to the subsequent treatment with gefitinib 2008 ·Lung Cancer ·Hiroshi Wataya, Tatsuro Okamoto, Riichiroh Maruyama, Takashi Seto, Koji Yamazaki, Tetsuzo Tagawa, Seiichi Fukuyama, Atsushi Osoegawa, Jirō Ikeda, (unknown), Takeharu Yamanaka, Yukito Ichinose	6
12	Establishment of a clinical pathway as an effective tool to reduce hospitalization and charges after video-assisted thoracoscopic pulmonary resection 2006 ·The Japanese Journal of Thoracic and Cardiovascular Surgery ·Riichiroh Maruyama, (unknown), (unknown), Yoshiro Aoki, Ryuichi Suemitsu, Tatsuro Okamoto, Hiroshi Wataya, Yukito Ichinose	27
13	Phase I Study of Amrubicin Hydrochloride and Cisplatin in Patients Previously Treated for Advanced Non-small Cell Lung Cancer 2006 ·Japanese Journal of Clinical Oncology ·Jirō Ikeda, Riichiroh Maruyama, Tatsuro Okamoto, Fumihiro Shoji, Hiroshi Wataya, Yukito Ichinose	4
14	Persistent and Aggressive Treatment for Thymic Carcinoma 2006 ·Oncology ·Riichiroh Maruyama, Ryuichi Suemitsu, Tatsuro Okamoto, (unknown), Yoshiro Aoki, Hiroshi Wataya, Takashi Eguchi, Kenichi Nishiyama, Takashi Seto, Yukito Ichinose	28
15	Triplet Chemotherapy with Cisplatin, Gemcitabine and Vinorelbine for Malignant Pleural Mesothelioma 2005 ·Japanese Journal of Clinical Oncology ·Riichiroh Maruyama, Fumihiro Shoji, Tatsuro Okamoto, Tetsuya Miyamoto, (unknown), Tomomi Nakamura, Jirō Ikeda, Yoshiro Aoki, Hiroshi Wataya, Hiroshi Asoh, Yukito Ichinose	13
16	Malignant schwannoma of the upper mediastinum originating from the vagus nerve 2005 ·World Journal of Surgical Oncology ·Fumihiro Shoji, Riichiroh Maruyama, Tatsuro Okamoto, Hiroshi Wataya, Kenichi Nishiyama, Yukito Ichinose	18
17	Long-term survival after an aggressive surgical resection and chemotherapy for stage IV pulmonary giant cell carcinoma 2005 ·World Journal of Surgical Oncology ·Fumihiro Shoji, Riichiroh Maruyama, Tatsuro Okamoto, Jirō Ikeda, Tomomi Nakamura, Hiroshi Wataya, Yukito Ichinose	8
18	Benign Metastasizing Leiomyoma of the Lung: a Case of Long-term Follow-up After Diagnosis 2003 ·Haigan ·Akira Nagashima, Masayuki Kawasaki, Hiroshi Wataya, Takashi Yoshimatsu, Toshihiro Osaki	2
19	Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma 2001 ·Cancer ·Miiru Izumi, Yoichi Nakanishi, Koichi Takayama, (unknown), Koji Inoue, Hiroshi Wataya, Takahiro Minami, Nobuyuki Hara	36
20	Quantitation of HLA-A∗0201 bound tumor associated antigens on a peptide pulsed B cell line 2001 ·Human Immunology ·Hiroshi Wataya, Nobuhiro Kamikawaji, Yoichi Nakanishi, Koichi Takayama, Nobuyuki Hara, Takehiko Sasazuki	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact